ArticleBMC cardiovascular disorders2022

Comprehensive safety profile evaluation of bivalirudin in Chinese ST-segment elevation myocardial infarction patients receiving percutaneous coronary intervention: a prospective, multicenter, intensive monitoring study.

Haijun Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.